Chikugo, Japan

Rumiko Masuda

This inventor holds 1 USPTO granted patent. Top assignee: Welfide Corporation. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rumiko Masuda. Retrieved from https://idiyas.com/inventor/rumiko-masuda-j41llm86

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rumiko Masuda: Innovator in Pharmaceutical Composition

Introduction

Rumiko Masuda is a notable inventor based in Chikujo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of drug compositions aimed at improving organ and bone marrow transplantation outcomes.

Latest Patents

Masuda holds a patent for a drug composition that includes 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol or a pharmaceutically acceptable acid addition salt thereof, combined with lecithin. This composition may also contain a saccharide, making it suitable for liquid preparations. It is designed to suppress rejection in organ or bone marrow transplantation, serve as an immunosuppressive sustention therapy, or treat autoimmune diseases. She has 1 patent to her name.

Career Highlights

Rumiko Masuda is currently employed at Welfide Corporation, where she continues to innovate in the pharmaceutical sector. Her work focuses on developing effective treatments that enhance patient outcomes in transplantation and autoimmune disease management.

Collaborations

Masuda collaborates with Atsushi Sakai, contributing to advancements in their shared field of expertise.

Conclusion

Rumiko Masuda's contributions to pharmaceutical compositions highlight her role as an influential inventor in the medical field. Her innovative work continues to pave the way for improved therapies in transplantation and autoimmune diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…